Latest news


Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.

1 2 3 4 > >>

Génome Québec recruits heavyweight of the Québec research community

Dec. 11, 2018

Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Serge Marchand as Vice President of Scientific Affairs – a decision unanimously endorsed by the Board of Directors. He will be taking up his duties on January 28, 2019.


More details...

Major breakthrough in the quest for cancer vaccine

Dec. 6, 2018

The team of Dr. Claude Perreault at the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal has successfully shown how a vaccine could work to fight several types of cancers.


More details...

A not-to-be-missed event!

Nov. 15, 2018

Génome Québec is pleased to be one of the partners of EFFERVESCENCE, a major event in the life science and health technologies sector.


More details...

Québec and France - United in making genomics work for Citizens and Society

Nov. 13, 2018

During the 31st edition of the Entretiens Jacques Cartier (EJC) being held in France, Génome Québec is pleased to announce that an international tripartite partnership agreement has been signed with the Université Jean Monnet de Saint-Étienne – Université de Lyon and the Cancéropôle Lyon Auvergne-Rhône-Alpes (CLARA). 


More details...

Génome Québec - Proud partner of the 12th Québec City Healthcare Industry Forum

Oct. 30, 2018

The Québec City Healthcare Industry Forum (FISQ) will take place December 5 and 6, at the Manège militaire Voltigeurs in Québec. Organized by Québec International, in collaboration with BIOQuébec, Génome Québec, Innovative medicines Canada and Norton Rose Fulbright.


More details...

Génome Québec welcomes genomics expert from France

Oct. 3, 2018

At the International Congress on Personalized Health Care, held at the Palais des congrès de Montréal from September 23 to 26, 2018, Professor Jean-François Deleuze, directeur du Centre national de recherche en génomique humaine, presented France’s 2025 Genomic Medicine Plan. Accompanied by Martin LeBlanc of Caprion and Dr. Tarik Möröy of the Montréal Clinical Research Institute (IRCM), Prof. Deleuze discussed France’s vision for the integration of genomics into clinical practice.

 

The discussion highlighted the difference between the French position, which focuses on a patient-centred approach and the clinical integration of genomics, and that of other countries. For instance, unlike the United Kingdom, whose strategy is more diversified, France has chosen to concentrate its efforts on developing a national medical and industrial sector in genomics medicine and on exporting this know-how.

 

The unique French approach was of interest to both panelists and participants, as it proved to be a source of inspiration for Québec and Canada. 


More details...

Génome Québec congratulates the new Government

Oct. 2, 2018

The President and CEO of Génome Québec, Daniel Coderre, would like to congratulate the new Premier of Québec, François Legault, and his team. The election of a majority Government that places economic prosperity at the top of its priorities is welcome news.


More details...

Harnessing Genomics to Improve Human Health and the Environment

Aug. 16, 2018

Génome Québec congratulates two Québec research teams who have been awarded major funding for projects in the sectors of human health and the environment. In total the teams secured funding of $5 million from a total of $21 million available across Canada under the Genome Canada Genomic Applications Partnership Program.


More details...

Génome Québec is proud to support the Genome Project-write Canada event

Aug. 10, 2018

The Genome Project-write (GP-write) is an open, international research project led by a multidisciplinary group of scientific leaders who will oversee a reduction in the costs of engineering and testing large genomes in cell lines by 1,000-fold within ten years.


More details...

Our new Annual Report is available online!

Aug. 2, 2018

We invite you to read our 2017-2018 Annual Report summarizing our activities.


Pleasant reading!


More details...

1 2 3 4 > >>